Skip to main navigation Skip to search Skip to main content

Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution

  • Doron Zahger
  • , Gregory G. Schwartz
  • , Michael Szarek
  • , Sergio Fazio
  • , P. Gabriel Steg
  • Soroka Medical Center
  • University of Colorado Anschutz Medical Campus
  • Regeneron Pharmaceuticals, Inc.
  • Université Paris Cité
  • Assistance publique – Hôpitaux de Paris
  • French Alliance for Cardiovascular Trials

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e55
JournalJournal of the American College of Cardiology
Volume85
Issue number4
DOIs
StatePublished - Feb 4 2025

Fingerprint

Dive into the research topics of 'Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution'. Together they form a unique fingerprint.

Cite this